Clinical Trials on Obstructed Defecation Syndrome (ODS) in United States
Total 197 results
-
Massachusetts General HospitalTerminatedObstructed Defecation Syndrome (ODS)United States
-
Croydon University HospitalCompletedObstructed Defaecation SyndromeUnited Kingdom
-
NorthShore University HealthSystemUniversity of Pittsburgh; Weill Medical College of Cornell UniversityRecruitingObstructed DefecationUnited States
-
Mayo ClinicEthicon Endo-SurgeryCompletedObstructive Defecation Syndrome | Outlet ObstructionUnited States
-
PersImmune, IncUniversity of California, San DiegoUnknown
-
Dana-Farber Cancer InstituteCompletedMyelodysplastic Syndromes (MDS)United States
-
SCRI Development Innovations, LLCNovartis PharmaceuticalsTerminated
-
Cyclacel Pharmaceuticals, Inc.SuspendedLeukemia | Myelodysplastic Syndrome(MDS)United States
-
AbbVieCelgene; Genentech, Inc.CompletedMyelodysplastic Syndromes (MDS)United States, Australia, Germany
-
AbbVieGenentech, Inc.Active, not recruitingMyelodysplastic Syndromes (MDS)United States, Australia, Canada, France, Germany, Italy, United Kingdom
-
Benjamin TomlinsonRecruitingMyelodysplastic Syndromes | MDS/MPN Crossover SyndromesUnited States
-
Sumitomo Pharma America, Inc.TerminatedMyelodysplastic Syndromes (MDS)United States
-
National Heart, Lung, and Blood Institute (NHLBI)National Cancer Institute (NCI)RecruitingMyelodysplastic Syndromes (MDS)United States, Israel
-
Sidney Kimmel Cancer Center at Thomas Jefferson...Celgene CorporationTerminatedMyelodysplastic Syndrome | MDS | Low to Intermediate-1 MDS | Non-deletion 5qUnited States
-
Stanford UniversityCelgene CorporationTerminatedLeukemia | Myelodysplastic Syndromes (MDS) | Acute Myeloid Leukemia (AML)United States
-
National Heart, Lung, and Blood Institute (NHLBI)Completed
-
Oncology Specialties, AlabamaTerminatedMyelodysplastic Syndrome (MDS)United States
-
Case Comprehensive Cancer CenterRecruitingMyelodysplastic Syndrome (MDS)United States
-
Weill Medical College of Cornell UniversityNovartis PharmaceuticalsCompletedMyelodysplastic Syndrome (MDS)United States
-
TelikCompletedMyelodysplastic Syndrome (MDS)United States
-
M.D. Anderson Cancer CenterNovartisCompletedMyelodysplastic Syndromes | MDSUnited States
-
Peter L GreenbergAmgenCompletedMyelodysplastic Syndromes | Myelodysplastic Syndromes (MDS) | Blood CancerUnited States
-
H. Lee Moffitt Cancer Center and Research InstituteGlaxoSmithKlineTerminatedThrombocytopenia | Myelodysplastic Syndrome (MDS)United States
-
Tarix PharmaceuticalsTerminatedMyelodysplastic Syndrome (MDS)United States
-
Kiadis PharmaNational Cancer Institute (NCI); National Heart, Lung, and Blood Institute... and other collaboratorsWithdrawnMyelodysplastic Syndromes (MDS) | Acute Myeloid Leukemia (AML)United States
-
H. Lee Moffitt Cancer Center and Research InstituteCelgene CorporationCompletedMyelodysplastic Syndrome | MDSUnited States
-
Cyclacel Pharmaceuticals, Inc.M.D. Anderson Cancer CenterCompleted
-
TelikTerminatedMyelodysplastic Syndrome (MDS)United States
-
Amphivena Therapeutics, Inc.CompletedMyelodysplastic Syndrome (MDS)United States
-
Aprea TherapeuticsTerminatedMyelodysplastic Syndromes | MDSUnited States
-
TelikTerminatedMyelodysplastic Syndrome (MDS)United States
-
Celgene CorporationCompletedLow- or Intermediate-1-risk Myelodysplastic Syndrome (MDS)United States
-
Rush University Medical CenterCelgene CorporationTerminated
-
Anjali SharathkumarAmgenActive, not recruitingThrombocytopenia | Bone Marrow Failure Disorders | Aplastic Anemia | Refractory Cytopenia of Childhood | Myelodysplastic Syndrome(MDS)United States
-
National Heart, Lung, and Blood Institute (NHLBI)RecruitingMyelodysplastic Syndrome (MDS) | Severe Aplastic Anemia | Hypo-Plastic MDSUnited States
-
Stanford UniversityNational Institutes of Health (NIH)CompletedMyelodysplastic Syndromes | Myeloproliferative Disorders | Myelodysplastic Syndromes (MDS) | Blood and Marrow Transplant (BMT) | Myeloproliferative Disorders (MPD)United States
-
Incyte CorporationTerminatedMDS (Myelodysplastic Syndrome)United States
-
Yale UniversityWithdrawn
-
Seagen Inc.CompletedMyelodysplastic Syndrome (MDS)United States
-
Gwynn Long, M.D.ADC Therapeutics S.A.TerminatedAcute Myeloid Leukemia (AML) | Myelodysplastic Syndrome (MDS) | Myeloproliferative Neoplasm (MDS/MPN)United States
-
Jacqueline Garcia, MDNational Institutes of Health (NIH)RecruitingAcute Myeloid Leukemia (AML) | Chronic Myelomonocytic Leukemia (CMML) | Myelodysplastic Syndrome (MDS) | Hematopoietic Stem Cell Transplant | MDS/Myeloproliferative Neoplasm-unclassifiable (MDS/MPN-unclassifiable)United States
-
Novartis PharmaceuticalsActive, not recruitingAcute Myeloid Leukemia (AML) | High-risk Myelodysplastic Syndrome (MDS)Spain, Singapore, Australia, Germany, Italy, Finland, United States
-
M.D. Anderson Cancer CenterRecruitingB-Cell Lymphoma | Myelodysplastic Syndromes (MDS) | Acute Myeloid Leukemia (AML)United States
-
Novartis PharmaceuticalsRecruitingMyelodysplastic Syndrome (MDS)United States
-
Michael SavonaIncyte Corporation; Astex Pharmaceuticals, Inc.; TheradexRecruiting
-
Ethicon Endo-SurgeryCompletedChronic Constipation | Intussusception | Rectocele | Obstructive Defecation SyndromeUnited States
-
Prof. Janet DunnKing's College Hospital NHS Trust; University of Manchester; University of Birmingham and other collaboratorsRecruitingMyelodysplastic Syndromes (MDS)United Kingdom
-
National Heart, Lung, and Blood Institute (NHLBI)CompletedMyelodysplastic Syndrome (MDS)United States
-
Nkarta Inc.Active, not recruitingMDS | AML, Adult | Relapsed/Refractory AML | Refractory Myelodysplastic SyndromesUnited States
-
Radboud University Medical CenterRecruitingMyelodysplastic Syndromes (MDS)Denmark, Switzerland, Serbia, Austria, Croatia, Czechia, France, Germany, Greece, Israel, Italy, Netherlands, Poland, Portugal, Romania, Spain, Sweden, United Kingdom